These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8352519)

  • 1. Effects of some ruthenium chelates on MCa mammary carcinoma and on TLX5 lymphoma in mice.
    Bregant F; Pacor S; Ghosh S; Chattopadhyay SK; Sava G
    Anticancer Res; 1993; 13(4):1011-7. PubMed ID: 8352519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of some rhodium(I) derivatives on MCa mammary carcinoma.
    Sava G; Pacor S; Ceschia V; Zassinovich G; Mestroni G
    Anticancer Res; 1989; 9(3):787-90. PubMed ID: 2764524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity.
    Bergamo A; Gava B; Alessio E; Mestroni G; Serli B; Cocchietto M; Zorzet S; Sava G
    Int J Oncol; 2002 Dec; 21(6):1331-8. PubMed ID: 12429985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion.
    Bergamo A; Stocco G; Casarsa C; Cocchietto M; Alessio E; Serli B; Zorzet S; Sava G
    Int J Oncol; 2004 Feb; 24(2):373-9. PubMed ID: 14719114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
    Velders AH; Bergamo A; Alessio E; Zangrando E; Haasnoot JG; Casarsa C; Cocchietto M; Zorzet S; Sava G
    J Med Chem; 2004 Feb; 47(5):1110-21. PubMed ID: 14971891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
    Scolaro C; Bergamo A; Brescacin L; Delfino R; Cocchietto M; Laurenczy G; Geldbach TJ; Sava G; Dyson PJ
    J Med Chem; 2005 Jun; 48(12):4161-71. PubMed ID: 15943488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model.
    Bergamo A; Masi A; Peacock AF; Habtemariam A; Sadler PJ; Sava G
    J Inorg Biochem; 2010 Jan; 104(1):79-86. PubMed ID: 19906432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of tumour infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A.
    Magnarin M; Bergamo A; Carotenuto ME; Zorzet S; Sava G
    Anticancer Res; 2000; 20(5A):2939-44. PubMed ID: 11062704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of a murine metastatic cell line and preliminary test of sensitivity to the anti-metastasis agent NAMI-A.
    Pacor S; Vadori M; Vita F; Bacac M; Soranzo MR; Zabucchi G; Sava G
    Anticancer Res; 2001; 21(4A):2523-30. PubMed ID: 11724317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse.
    Sava G; Ceschia V; Pacor S; Zorzet S; Perissin L
    Methods Find Exp Clin Pharmacol; 1989 Nov; 11(11):683-9. PubMed ID: 2622298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
    Sava G; Zorzet S; Turrin C; Vita F; Soranzo M; Zabucchi G; Cocchietto M; Bergamo A; DiGiovine S; Pezzoni G; Sartor L; Garbisa S
    Clin Cancer Res; 2003 May; 9(5):1898-905. PubMed ID: 12738748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structure and spectral and redox properties of new mixed ligand monomeric and dimeric Ru(II) complexes: predominant formation of the "cis-alpha" diastereoisomer and unusual 3MC emission by dimeric complexes.
    Murali M; Palaniandavar M
    Dalton Trans; 2006 Feb; (5):730-43. PubMed ID: 16429178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
    Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
    Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel ruthenium complex K2[Ru(dmgly)Cl4].2H2O is toxic to C6 astrocytoma cell line, but not to primary rat astrocytes.
    Djinović V; Momcilović M; Grgurić-Sipka S; Trajković V; Mostarica Stojković M; Miljković D; Sabo T
    J Inorg Biochem; 2004 Dec; 98(12):2168-73. PubMed ID: 15541507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds.
    Karki SS; Thota S; Darj SY; Balzarini J; De Clercq E
    Bioorg Med Chem; 2007 Nov; 15(21):6632-41. PubMed ID: 17765549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition.
    Sava G; Pacor S; Bergamo A; Cocchietto M; Mestroni G; Alessio E
    Chem Biol Interact; 1995 Mar; 95(1-2):109-26. PubMed ID: 7697744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment.
    Pacor S; Zorzet S; Cocchietto M; Bacac M; Vadori M; Turrin C; Gava B; Castellarin A; Sava G
    J Pharmacol Exp Ther; 2004 Aug; 310(2):737-44. PubMed ID: 15075381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed-valent metals bridged by a radical ligand: fact or fiction based on structure-oxidation state correlations.
    Sarkar B; Patra S; Fiedler J; Sunoj RB; Janardanan D; Lahiri GK; Kaim W
    J Am Chem Soc; 2008 Mar; 130(11):3532-42. PubMed ID: 18290644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranilast inhibits the growth and metastasis of mammary carcinoma.
    Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
    Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.